2-{1-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}-2,3-dihydro-1H-isoindole-1,3-dione

Catalog No. :
ACXZRP476
CAS No. :
1795518-55-6
Molecular Formula :
C18H12FN3O2S
Molecular Weight :
353.38

IUPAC Name:2-(1-(5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl)ethyl)isoindoline-1,3-dione

2-{1-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}-2,3-dihydro-1H-isoindole-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$227.00Login to see priceInquiryInquiry
100mg95%$330.00Login to see priceInquiryInquiry
250mg95%$466.00Login to see priceInquiryInquiry
1g95%$923.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{1-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}-2,3-dihydro-1H-isoindole-1,3-dione
IUPAC Name2-(1-(5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl)ethyl)isoindoline-1,3-dione
MDL No.MFCD26936146
Molecular FormulaC18H12FN3O2S
Molecular Weight353.38
SMILESO=C1N(C(C2=NN=C(C3=CC=CC=C3F)S2)C)C(C4=C1C=CC=C4)=O
InChI KeyBWBLNCQQGNIEHM-UHFFFAOYSA-N
Synonym1H-Isoindole-1,3(2H)-dione, 2-[1-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl]-;2-{1-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]ethyl}-2,3-dihydro-1H-isoindole-1,3-dione
CAS No.1795518-55-6

Synthetic Route by SureRoute

1. ACXZRP476 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACXZRP476 route product structure diagram
    ACXZRP4761795518-55-6
Inquiry

2. ACXZRP476 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  4. Then
  5. ACXZRP476 route product structure diagram
    ACXZRP4761795518-55-6
Inquiry

Comments (0)